Procter & Gamble Health Limited
NSE PGHL.NS
Procter & Gamble Health Limited Free Cash Flow Per Share for the year ending June 30, 2024: USD 1.49
-
Procter & Gamble Health Limited Free Cash Flow Per Share for the year ending June 30, 2023 was USD 1.42, a 41.55% change year over year.
-
Procter & Gamble Health Limited Free Cash Flow Per Share for the year ending June 30, 2022 was USD 1.00, a -36.36% change year over year.
-
Procter & Gamble Health Limited Free Cash Flow Per Share for the year ending June 30, 2021 was USD 1.58, a -27.43% change year over year.
-
Procter & Gamble Health Limited Free Cash Flow Per Share for the year ending June 30, 2020 was USD 2.17, a 260.01% change year over year.
| Date | Free Cash Flow Per Share | Return on Assets (ROA) | Return on Equity (ROE) | Return on Capital Employed (ROCE) |
|---|
| CEO | Mr. Milind Vasant Thatte M.B.A. |
| IPO Date | July 1, 2002 |
| Location | India |
| Headquarters | Godrej One |
| Employees | 1,407 |
| Sector | Health Care |
| Industries | |
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.
Past 5 years
USD 64.30
USD 326.23
USD 81.26
USD 169.55
USD 58.78
StockViz Staff
January 15, 2025
Any question? Send us an email